MedTrace Logo

Optimization and Follow-up of the Consecutive Use of Two Intragastric Balloons in the Treatment of Obesity

NCT03102697 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2022-08-17

No results posted yet for this study

Summary

This is a cohort study with the objective of describing during a 12-month follow-up, weight loss in obese patients submitted to treatment using two consecutively air-filled IGB (Heliosphere® 600 cc and Heliosphere 720 cc) without any interval between the removal of the first and the placement of the second.

Conditions

Interventions

DEVICE

Air-filled Intragastric balloon

Weight loss system that consists of an air balloon that occupies space in the stomach, thus reducing the gastric capacity and leaving less volume for food.

Sponsors & Collaborators

  • Kaiser Clinic and Hospital

    lead OTHER

Principal Investigators

  • Eduardo Grecco, MD · School of Medicine of ABC, Santo Andre/SP Brazil

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2019-10-01
Completion
2020-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03102697 on ClinicalTrials.gov